HEALTHCARE
STEM CELL BANKING MARKET Forecast To 2021
STEM CELL BANKING MARKET – FORECAST TO 2021 By Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), By Region
REPORT OVERVIEW 1.1
OBJECTIVES OF THE STUDY •
To define, describe, and forecast the stem cell banking market based on type, service, and application
•
To provide detailed information regarding major factors, such as drivers, restraints, and opportunities influencing the growth of the market
•
To strategically analyze the market with respect to individual growth trends, future prospects, and contributions to the overall market
•
To forecast the size of the market segments with respect to the four main regions, namely, North America, Europe, Asia, and Rest of the World (RoW)
•
To strategically profile the key players and comprehensively analyze their market shares and core competencies
•
To track and analyze competitive developments, such as joint ventures, mergers, acquisitions, expansions and research and development activities in the stem cell banking market
sales@marketsandmarkets.com
www.marketsandmarkets.com
1
INTRODUCTION
1.2
MARKET DEFINITION
•
Stem cell banking is the process of collecting and storing stem cells with the intent of future potential use either in treatment or in research. There are various sources from which stem cells can be retrieved. Umbilical cord blood and cord tissue banking is the process of collecting and storing the cord blood and/or cord tissue to retrieve stem cells from them whenever required. Cord blood and cord tissue contain hematopoietic, mesenchymal, and epithelial type of stem cells that find wide applications in the field of cell-based therapies. These stored stem cells are used to treat various disorders and diseases, such as leukemia, anemia, metabolic and hereditary disorders along with many others as well as for a number of clinical trials to bring about reforms in stem cell-based therapeutics. Stem cells possess the property of self-renewal and differentiation that have led to their use in the medical field for research activities across various branches.
1.3
MARKET SCOPE
1.3.1 MARKETS COVERED •
MARKET SEGMENTATION BY BANK TYPE
BY APPLICATION
BY SERVICE
BY REGION
Cord Blood Bank
Cerebral Palsy
Collection & Transportation
North America
Cord Blood & Cord Tissue Bank
Leukemia
Analysis
Asia-Pacific
Thalassemia
Processing
Anemia
Storage
Rest of the World (RoW)
Europe
Autism Diabetes Others
•
Source: Secondary Research and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
2
INTRODUCTION
1.3.2 YEARS CONSIDERED IN THE STUDY
2021-p
• 2016-e 2015 2014
HISTORICAL YEAR
BASE YEAR
FORECAST PERIOD
PROJECTED YEAR
•
1.4 CURRENCY •
The currency used in this report is USD, with market size being indicated in terms of USD million. •
For companies reporting their revenue in USD, the revenues were taken from their annual reports
•
For companies that reported their revenue in other currencies, the average annual currency conversion rate was used for the particular year to convert the value to USD.
1.5 LIMITATIONS •
The company developments that were not reported in the public domain have not included in this report.
•
Some of the companies in this market are privately owned and their revenues are not available in the public domain. Hence, the revenues for those companies have not been mentioned in this report.
•
Stem cell retrived from cord blood & cord tissue are included in this report. The stem cells from other sources are not included in the scope of this study.
1.6 STAKEHOLDERS •
Government and Research Organization
•
Hospitals
•
Clinics
•
Private Medical Institutes
•
Companies in the Stem Cell Banking Sector
sales@marketsandmarkets.com
www.marketsandmarkets.com
3
RESEARCH METHODOLOGY
2.1
RESEARCH DATA
•
This research study involved the extensive use of secondary sources, directories, and databases, such as Hoovers, Bloomberg Business, and Factiva; white papers; annual reports, company house documents and SEC filings of the company. Secondary research was mainly used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the stem cell banking market. It was also used to obtain key information about the market classification and segmentation according to the industry trends, regional markets developments related to the market, and technology perspectives. Primary sources were mainly industry experts from core and related industries and preferred service providers, technology developers, alliances, standards and certification organizations, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted from various primary respondents, including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess future prospects. The following figure shows the market research methodology applied in this market report. • FIGURE 1 •
STEM CELL BANKING MARKET: RESEARCH DESIGN
CURRENT MARKET INFORMATION AND DATA
RESEARCH METHODOLOGY COMPANY REVENUES MARKET SIZE MARKET SHARE
MARKET DRIVERS: • Easy extraction method • Rising numbers of new born • Technological advancements
INFLUENCING FACTORS (Market Trends and Dynamics)
• Rising number of potentially treatable diseases with stem cell therapy • Growth in GDP and urban disposable income with increasing focus and awareness on healthcare
AND R&D EXPENSES
GEOGRAPHICAL USAGE PATTERN
COMPANY DEVELOPMENTS
COMPETITIVE LANDSCAPE
MARKET RESTRAINTS:
MARKET OPPORTUNITIES:
• High competition in the stem cell banking market
• Rising awareness about potential use of cord tissue
• Huge initial investment and high operating cost
• Increasing parenteral awareness
• Changes in legal regulations
• The automation of procedures
• Lack of acceptance
WINNING IMPERATIVES
• AGREEMENTS, COLLABORATIONS, & PARTNERSHIPS • NEW PRODUCT LAUNCHES • ACQUISITIONS
MARKET SIZE & SHARE ANALYSIS
FORECAST
• By Application • By Type
HIGH GROWTH SEGMENTS
•
MARKET SIZE & FORECAST:
• By Service • By Region
SUPPLY AND DEMAND SIDE FACTORS
PEST ANALYSIS & GEOGRAPHIC USAGE PATTERN
ARRIVE AT THE MARKET SIZE, SHARE, AND CAGR FOR THE GLOBAL WOUND DRESSINGS MARKET
Source: Secondary Research and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
4
RESEARCH METHODOLOGY
•
In the secondary research process, various secondary sources were referred to identify and collect useful information for the study. These resources include annual reports, press releases, investor presentations of companies, white papers, certified publications, articles from recognized authors gold and silver standard websites, databases, and directories.
•
Secondary research was mainly used to obtain key information about the industry’s key value chain, market classification and segmentation according to the industry trends, geographical market, and key developments from both market and technology- oriented perspectives.
•
After the complete market engineering (which includes calculations for market statistics, market breakdown, market size estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also carried out to identify the segmentation types and market dynamics, such as drivers, restraints, and opportunities.
•
In the primary research process, various primary sources from the supply side were interviewed to obtain both qualitative and quantitative information for this report. Primary sources included industry experts such as Chief Executive Officers (CEOs), Vice Presidents (VP), marketing directors, key executives, distributors, surgeons, physicians, and experts from research institutes.
•
In the complete market engineering process, both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout this report.
2.1.1 KEY DATA FROM SECONDARY SOURCES SECONDARY SOURCES
PARAMETERS
•
MARKET SIZE
• • • • • •
Company Financials Magazines Journals Press Releases Paid Databases MarketsandMarkets Data Repository
REVENUE OF COMPANIES
• • • •
Annual Reports Company Websites Public Databases MarketsandMarkets Data Repository
• • • •
Company Websites Annual Reports Press Releases, and The MarketsandMarkets Data Repository
QUALITATIVE INFORMATION (Market Dynamics and Trends)
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
5
RESEARCH METHODOLOGY
2.1.2 KEY DATA FROM PRIMARY SOURCES TYPES
•
REGIONAL SPLIT
GLOBAL MARKET SIZE
PARAMETERS
DATA
Overall market and subsegments in 2015
Global stem cell banking market, by region – North America, Europe, Asia, and Rest of the World (RoW)
Global stem cell banking market estimates
Global stem cell banking market, by segment
Historical growth rates
Global stem cell banking market, by type
Global stem cell banking market, by application
Global stem cell banking market, by service
CAGR of each region in the forecast period (2016–2021)
The global market size for 2015 CAGR for the forecast period (2016–2021)
Percentage split of market segments
MARKET SPLIT
Relative growth rates of each segment
•
2.1.2.1 BREAKDOWN OF PRIMARY INTERVIEWS • FIGURE 2 •
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
BY COMPANIES
20%
BY DESIGNATION
•
31% 19%
19%
49%
Tier 2
17%
28%
31% 53%
Tier 1
BY REGION
33% Tier 3
C-Level Others
Director-Level
North America
Europe
Asia-Pacific
RoW
Note: *Others include sales managers, marketing managers, and product managers. Tier 1 companies have revenues above USD 500 million, Tier 2 companies have revenues between USD 100 million and USD 500 million, and Tier 3 companies have revenues less than USD 100 million.
sales@marketsandmarkets.com
www.marketsandmarkets.com
6
RESEARCH METHODOLOGY
2.2
MARKET SIZE ESTIMATION
•
The top-down and bottom-up approaches have been used to estimate and validate the size of the market and to estimate the sizes of various other dependent submarkets in the overall stem cell banking market. The research methodology used, key players in the market have been identified through secondary research and their market shares in respective regions have been determined through primary and secondary research. This entire procedure includes the study of annual and financial reports of top market players and extensive interviews to gain key insights from industry leaders, such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. • FIGURE 3
BOTTOM-UP APPROACH
•
TOTAL MARKET SIZE Global Stem Cell Banking Market
Share of Companies’ Revenues in the Stem Cell Banking Segment
Total Players’ Revenues in the Global Stem Cell Banking Market
PRIMARY SOURCES: Demand and Supply Side Experts SECONDARY SOURCES: Annual Reports, Presentations, Press Releases, Journals, Paid Databases, Company Websites, News Articles, and MarketsandMarkets Repository
•
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
7
RESEARCH METHODOLOGY
• FIGURE 4
TOP-DOWN APPROACH
• Global Stem Cell Banking Market
GLOBAL MARKET SIZE IS VALIDATED THROUGH PRIMARIES (Demand & Supply Side Experts)
Regional Split
Percentage Split for the Segments of the Global Stem Cell Banking Market Country Level Market for Each Subsegments
PRIMARY SOURCES: Demand and Supply Side Experts
SECONDARY SOURCES: Annual Reports, Presentations, Press Releases, Journals, Paid Databases, and MarketsandMarkets Repository
•
•
The bottom-up approach has been used to arrive at the overall size of the stem cell banking market from the revenue of key players (companies) and their shares in the market. The bottom-up approach has also been used for the data extracted from secondary research to validate the market sizes of segments in terms of value.
•
Market shares have been estimated for each company to verify the revenue shares used earlier in the bottom-up approach. With the data triangulation procedure and validation of data through primary interviews, the estimated values of the overall parent market and individual market sizes have been determined and confirmed in this study. The data triangulation procedure implemented for this study is explained in the next section.
sales@marketsandmarkets.com
www.marketsandmarkets.com
8
RESEARCH METHODOLOGY
2.3
MARKET BREAKDOWN AND DATA TRIANGULATION
•
After arriving at the overall market size from the market size estimation process mentioned above, the total market was split into several segments. In order to complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply side. Along with this, the market was validated using the top-down and bottom-up approaches. •
DEMAND SIDE
PRIMARY SOURCES
SECONDARY SOURCES
INTERVIEWS WITH: • Physicians and Nurses • Stem Cell Banking Associations
MnM KNOW*
INTERVIEWS WITH: • CEOs • Presidents
SUPPLY SIDE
•
International Society for Stem Cell Research (ISSCR)
•
National Stem Cell Foundation
•
National Marrow Donor Program
•
Cerebral Palsy Stem Cell Treatment
•
National Institute of Neurological Disorders and Strokes
•
Annual Review of Cell and Developmental Biology
•
Parent's Guide to Cord Blood Foundation
• Gynecologist and Pediatrician
• Vice-presidents • Marketing Managers • Business Managers
PRIMARY SOURCE
DATA TRIANGULATION
• Product Managers
SECONDARY SOURCE
• Sales Executives • Other stem cell banking marketrelated persons to get insights on the market size, market growth, key players, strategies, and market shares
Annual Reports, Presentations, Websites and Press Releases of Top Players, News Articles, Journals, and Paid Databases
INFORMATION SOURCED
Key Players
Opportunities/ Challenges
Competitive Landscape
Drivers and Restraints
Forecast
Market Size (2015) and Market Share (2015)
Regional Analysis
MnM KNOW* stands for MarketsandMarkets’ 'Knowledge Asset Management' framework. In this context, it stands for existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources . •
sales@marketsandmarkets.com
www.marketsandmarkets.com
9
RESEARCH METHODOLOGY
2.4
RESEARCH ASSUMPTIONS
2.4.1 ASSUMPTIONS ASSUMPTION
TYPES
•
GENERAL ASSUMPTIONS
MARKET SIZE & ESTIMATION
EXCHANGE RATE
POLITICAL STABILITY
• The numbers may not match up due to rounding-off at subsequent levels.
• Effect of inflation on the prices has not considered during the forecast period.
• Average rate for each year has been taken from respective period data.
• Political instability and the tensions prevailing in some regions will not hamper the estimates for the sizing and consequent growth of the market being studied.
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
10
TABLE OF CONTENTS
1 INTRODUCTION.........................................................................................................................12 •
1.1
OBJECTIVE OF THE STUDY.............................................................................................................................................12
•
1.2
MARKET DEFINITION.......................................................................................................................................................12
•
1.3
MARKET SCOPE...............................................................................................................................................................13
•
1.3.1
MARKETS COVERED......................................................................................................................................13
•
1.3.2
YEARS CONSIDERED IN THE STUDY............................................................................................................13
•
1.4 CURRENCY......................................................................................................................................................................14
•
1.5 LIMITATIONS....................................................................................................................................................................14
•
1.6 STAKEHOLDERS...............................................................................................................................................................14
2
RESEARCH METHODOLOGY.....................................................................................................15 •
2.1
RESEARCH DATA..............................................................................................................................................................15
•
2.1.1
KEY DATA FROM SECONDARY SOURCES.....................................................................................................17
•
2.1.2
KEY DATA FROM PRIMARY SOURCES..........................................................................................................18
•
2.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS.................................................................................18
•
2.2
MARKET SIZE ESTIMATION.............................................................................................................................................19
•
2.3
MARKET BREAKDOWN AND DATA TRIANGULATION......................................................................................................21
•
2.4
RESEARCH ASSUMPTIONS.............................................................................................................................................22
•
2.4.1 ASSUMPTIONS..............................................................................................................................................22
3
EXECUTIVE SUMMARY..............................................................................................................23
4
PREMIUM INSIGHTS.................................................................................................................25 •
5
4.1
ATTRACTIVE OPPORTUNITIES IN THE STEM CELL BANKING MARKET..........................................................................25
MARKET OVERVIEW..................................................................................................................28 •
5.1
MARKET SEGMENTATION................................................................................................................................................28
•
5.1.1
STEM CELL BANKING, BY BANK TYPE.........................................................................................................28
•
5.1.2
STEM CELL BANKING, BY SERVICE..............................................................................................................29
•
5.1.3
STEM CELL BANKING, BY APPLICATION......................................................................................................29
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
11
TABLE OF CONTENTS
•
5.2
MARKET DYNAMICS........................................................................................................................................................30
•
5.2.1 DRIVERS........................................................................................................................................................31
•
5.2.1.1
EASY EXTRACTION METHODS.................................................................................................31
•
5.2.1.2
RISING NUMBER OF NEWBORNS............................................................................................31
•
5.2.1.3
GROWTH IN GDP, DISPOSABLE INCOME, AND INCREASED AWARENESS OF STEM CELL THERAPEUTICS.........................................................................32
•
5.2.1.4
POTENTIAL OF STEM CELLS IN DISEASE TREATMENT...........................................................32
• •
5.2.2.1
HIGH COMPETITION IN THE STEM CELL BANKING MARKET.................................................32
•
5.2.2.2
HIGH OPERATING COST...........................................................................................................32
•
5.2.2.3
LACK OF ACCEPTANCE............................................................................................................32
•
5.2.2.4
CHANGES IN LEGAL REGULATIONS........................................................................................33
•
5.2.3 OPPORTUNITIES............................................................................................................................................33
•
5.2.3.1
RISING AWARENESS ABOUT POTENTIAL USE OF CORD TISSUE...........................................33
•
5.2.3.2
COLLABORATIONS AMONG CORD BLOOD BANKS.................................................................33
•
5.2.3.3
THE AUTOMATION OF PROCEDURES......................................................................................33
• •
6
5.2.2 RESTRAINTS..................................................................................................................................................32
5.2.4 CHALLENGES................................................................................................................................................33 5.2.4.1
ENTRY BARRIERS IN THE MARKET..........................................................................................33
STEM CELL BANKING MARKET, BY BANK TYPE.......................................................................34 •
6.1 INTRODUCTION...............................................................................................................................................................35
•
6.2
CORD BLOOD...................................................................................................................................................................37
•
6.3
CORD TISSUE..................................................................................................................................................................39
7
STEM CELL BANKING MARKET, BY SERVICE............................................................................43 •
7.1 INTRODUCTION...............................................................................................................................................................44
•
7.2
•
7.3 PROCESSING...................................................................................................................................................................47
•
7.4 ANALYSIS.........................................................................................................................................................................49
•
7.5 STORAGE.........................................................................................................................................................................50
COLLECTION & TRANSPORTATION.................................................................................................................................46
sales@marketsandmarkets.com
www.marketsandmarkets.com
12
TABLE OF CONTENTS
8
STEM CELL BANKING MARKET, BY APPLICATION....................................................................52 •
8.1 INTRODUCTION...............................................................................................................................................................53
•
8.2
•
8.3 THALASSEMIA.................................................................................................................................................................58
•
8.4 LEUKEMIA........................................................................................................................................................................60
•
8.5 DIABETES.........................................................................................................................................................................63
•
8.6 AUTISM............................................................................................................................................................................64
•
8.7 OTHERS............................................................................................................................................................................65
9
CEREBRAL PALSY............................................................................................................................................................56
STEM CELL BANKING MARKET, BY REGION.............................................................................67 •
9.1 INTRODUCTION...............................................................................................................................................................68
•
9.2
•
•
•
NORTH AMERICA.............................................................................................................................................................70
•
9.2.1
NORTH AMERICA, BY COUNTRY...................................................................................................................72
•
9.2.2
NORTH AMERICA, BY TYPE...........................................................................................................................72
•
9.2.3
NORTH AMERICA, BY SERVICE.....................................................................................................................73
•
9.2.4
NORTH AMERICA, BY APPLICATION.............................................................................................................73
9.3 EUROPE............................................................................................................................................................................74 •
9.3.1
EUROPE, BY COUNTRY.................................................................................................................................76
•
9.3.2
EUROPE, BY TYPE.........................................................................................................................................76
•
9.3.3
EUROPE, BY SERVICE....................................................................................................................................77
•
9.3.4
EUROPE, BY APPLICATION............................................................................................................................77
9.4 ASIA-PACIFIC..................................................................................................................................................................78 •
9.4.1
ASIA-PACIFIC, BY COUNTRY........................................................................................................................80
•
9.4.2
ASIA-PACIFIC, BY TYPE................................................................................................................................80
•
9.4.3
ASIA-PACIFIC, BY SERVICE..........................................................................................................................81
•
9.4.4
ASIA-PACIFIC, BY APPLICATION..................................................................................................................82
9.5
REST OF THE WORLD (ROW)...........................................................................................................................................83
•
9.5.1
REST OF THE WORLD, BY TYPE....................................................................................................................83
•
9.5.2
REST OF THE WORLD, BY SERVICE..............................................................................................................83
•
9.5.3
REST OF THE WORLD, BY APPLICATION......................................................................................................84
sales@marketsandmarkets.com
www.marketsandmarkets.com
13
TABLE OF CONTENTS
10
COMPETITIVE LANDSCAPE.......................................................................................................85
•
10.1
COMPANY SHARE ANALYSIS..........................................................................................................................................85
•
10.2
NEW SERVICE/PRODUCT LAUNCHES.............................................................................................................................86
•
10.3
MERGERS & ACQUISITIONS............................................................................................................................................87
•
10.4
REGULATORY APPROVALS..............................................................................................................................................87
•
10.5 PARTNERSHIPS................................................................................................................................................................88
•
10.6
•
10.7 AGREEMENTS..................................................................................................................................................................88
•
10.8 COLLABORATIONS...........................................................................................................................................................88
•
10.9
•
10.10 PATENT............................................................................................................................................................................89
•
10.11 GEOGRAPHICAL EXPANSION..........................................................................................................................................90
•
10.12 OTHERS............................................................................................................................................................................90
11
JOINT VENTURE...............................................................................................................................................................88
TECHNOLOGICAL UPDATE..............................................................................................................................................89
COMPANY PROFILE...................................................................................................................91 •
(Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*
•
11.1
•
11.2 CORDLIFE........................................................................................................................................................................94
•
11.3 CRYO-CELL......................................................................................................................................................................97
•
11.4
•
11.5 LIFECELL........................................................................................................................................................................101
•
11.6 STEMCYTE.....................................................................................................................................................................103
•
11.7 VIACORD........................................................................................................................................................................104
•
11.8
SMART CELLS INTERNATIONAL LTD.............................................................................................................................106
•
11.9
CRYOVIVA INDIA............................................................................................................................................................107
•
11.10 CORDVIDA.....................................................................................................................................................................109
•
11.11 CHINA CORD BLOOD CORPORATION............................................................................................................................110
•
CBR SYSTEMS, INC.........................................................................................................................................................91
CRYO-SAVE AG (A GROUP OF ESPERITE).......................................................................................................................99
*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.
sales@marketsandmarkets.com
www.marketsandmarkets.com
14
TABLE OF CONTENTS
12 APPENDIX................................................................................................................................112 •
12.1
INSIGHTS FROM INDUSTRY EXPERTS..........................................................................................................................112
•
12.2
DISCUSSION GUIDE......................................................................................................................................................113
•
12.3
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL...................................................................115
•
12.4
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE..............................................................................................117
•
12.5
AVAILABLE CUSTOMIZATIONS......................................................................................................................................118
•
12.6
RELATED REPORTS........................................................................................................................................................119
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
15
LIST OF TABLES
• TABLE 1
GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE, 2014-2021 (UNITS)...............................................35
• TABLE 2
STEM CELL BANKING MARKET VOLUME, BY BANK TYPE, 2016 (%)..............................................................36
• TABLE 3
STEM CELL BANKING MARKET, BY BANK TYPE, 2014-2021 (USD MILLION).................................................36
• TABLE 4
STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2016 (%).................................................................36
• TABLE 5
CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS)............................................37
• TABLE 6
CORD BLOOD STEM CELL BANKING MARKET VOLUME, BY REGION, 2016 (%)............................................38
• TABLE 7
CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION)...............................................................................................................................38
• TABLE 8
CORD BLOOD STEM CELL BANKING MARKET VALUE, BY REGION, 2016 (%)................................................39
• TABLE 9
GLOBAL CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS).......................................................................................................................40
• TABLE 10
CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET VOLUME, BY REGION, 2016 (%)........................................................................................................................................40
• TABLE 11
GLOBAL CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION)...........................................................................................................41
• TABLE 12
CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET VALUE, BY REGION, 2016 (%)........................................................................................................................................42
• TABLE 13
STEM CELL BANKING MARKET, BY SERVICES, 2014-2021 (USD MILLION)...................................................45
• TABLE 14
STEM CELL BANKING MARKET VALUE, BY SERVICES, 2016 & 2021 (%).......................................................45
• TABLE 15
STEM CELL BANKING MARKET FOR COLLECTION & TRANSPORTATION, BY REGION, 2014-2021 (USD MILLION)...........................................................................................................47
• TABLE 16
STEM CELL BANKING MARKET FOR PROCESSING, BY REGION, 2014-2021 (USD MILLION)...............................................................................................................................48
• TABLE 17
STEM CELL BANKING MARKET FOR ANALYSIS, BY REGION, 2014-2021 (USD MILLION)...............................................................................................................................49
• TABLE 18
STEM CELL BANKING MARKET FOR STORAGE, BY REGION, 2014-2021 (USD MILLION)...............................................................................................................................51
• TABLE 19
NUMBER OF SAMPLES USED FOR APPLICATION, 2014-2021 (UNITS)...........................................................53
• TABLE 20
STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)..........................................................54
• TABLE 21
STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (%).................................................................55
• TABLE 22
NUMBER OF STEM CELL UNITS RELEASED FOR APPLICATION MARKET, BY REGION, 2014-2021 (UNITS).......................................................................................................................56
• TABLE 23
NUMBER OF CLINICAL TRIALS USING STEM CELLS FROM CORD BLOOD AND CORD TISSUE IN CEREBRAL PALSY TREATMENT FROM 2014-2016...............................................................57
sales@marketsandmarkets.com
www.marketsandmarkets.com
16
LIST OF TABLES
• TABLE 24
STEM CELL BANKING MARKET IN CEREBRAL PALSY, BY REGION, 2014-2021 (UNITS)............................................................................................................................................58
• TABLE 25
STEM CELL BANKING MARKET IN THALASSEMIA, BY REGION, 2014-2021 (UNITS)......................................59
• TABLE 26
STEM CELL BANKING MARKET IN LEUKEMIA, BY REGION, 2014-2021 (UNITS)............................................61
• TABLE 27
STEM CELL BANKING MARKET IN ANEMIA, BY REGION, 2014-2021 (UNITS)................................................62
• TABLE 28
STEM CELL BANKING MARKET IN DIABETES, BY REGION, 2014-2021 (UNITS).............................................63
• TABLE 29
STEM CELL BANKING MARKET IN AUTISM, BY REGION, 2014-2021 (UNITS)................................................65
• TABLE 30
STEM CELL BANKING MARKET IN OTHERS, BY REGION, 2014-2021 (UNITS)................................................66
• TABLE 31
STEM CELL BANKING MARKET, OVERVIEW, 2014-2021..................................................................................68
• TABLE 32
STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS)...................................................................69
• TABLE 33
STEM CELL BANKING MARKET VOLUME, BY REGION, 2014-2021 (%)..........................................................69
• TABLE 34
STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION).......................................................70
• TABLE 35
STEM CELL BANKING MARKET VALUE, BY REGION, 2014-2021 (%)..............................................................70
• TABLE 36
NORTH AMERICA STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS)...................................72
• TABLE 37
NORTH AMERICA STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)...............................................................................................................................72
• TABLE 38
NORTH AMERICA STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)...........................................72
• TABLE 39
NORTH AMERICA STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)...............................................................................................................................72
• TABLE 40
NORTH AMERICA STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)..............................................................................................................................73
• TABLE 41
NORTH AMERICA STEM CELL BANKING MARKET, USAGE, 2014-2021...........................................................73
• TABLE 42
NORTH AMERICA STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)............................................................................................................................................73
• TABLE 43
EUROPE STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS)..................................................76
• TABLE 44
EUROPE STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)......................................76
• TABLE 45
EUROPE STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS).........................................................76
• TABLE 46
EUROPE STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION).............................................77
• TABLE 47
EUROPE STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)......................................77
• TABLE 48
EUROPE STEM CELL BANKING MARKET, USAGE, 2014-2021.........................................................................77
• TABLE 49
EUROPE STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)...........................................78
• TABLE 50
ASIA-PACIFIC STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS).........................................80
sales@marketsandmarkets.com
www.marketsandmarkets.com
17
LIST OF TABLES
• TABLE 51
ASIA-PACIFIC STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)...............................................................................................................................80
• TABLE 52
ASIA-PACIFIC STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)................................................80
• TABLE 53
ASIA-PACIFIC STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)....................................81
• TABLE 54
ASIA-PACIFIC STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)..............................................................................................................................81
• TABLE 55
ASIA-PACIFIC STEM CELL BANKING MARKET, USAGE, 2014-2021................................................................82
• TABLE 56
ASIA-PACIFIC STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)..................................82
• TABLE 57
REST OF THE WORLD STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)....................................83
• TABLE 58
REST OF THE WORLD STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)...............................................................................................................................83
• TABLE 59
REST OF THE WORLD STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)..............................................................................................................................83
• TABLE 60
REST OF THE WORLD STEM CELL BANKING MARKET, USAGE, 2014-2021....................................................84
• TABLE 61
REST OF THE WORLD STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)............................................................................................................................................84
• TABLE 62
STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2015 (%).......................................................86
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
18
LIST OF FIGURES
• FIGURE 1
STEM CELL BANKING MARKET: RESEARCH DESIGN.......................................................................................16
• FIGURE 2
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION..........................................................................................................................................................18
• FIGURE 3
BOTTOM-UP APPROACH..................................................................................................................................19
• FIGURE 4
TOP-DOWN APPROACH....................................................................................................................................20
• FIGURE 5
GLOBAL STEM CELL BANKING MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD......................................................................................................25
• FIGURE 6
THE PROCESSING SERVICES SEGMENT EXPECTED TO LEAD THE STEM CELL BANKING MARKET IN 2016....................................................................................................26
• FIGURE 7
ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD....................................................................................................................................27
• FIGURE 8
STEM CELL BANKING MARKET, BY BANK TYPE, 2016 & 2021 (UNITS)..........................................................35
• FIGURE 9
STEM CELL BANKING MARKET, BY BANK TYPE, 2016 & 2021 (USD MILLION)..............................................36
• FIGURE 10
CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (UNITS).........................................37
• FIGURE 11
CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (USD MILLION)............................................................................................................................38
• FIGURE 12
CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (UNITS)........................................................................................................................................40
• FIGURE 13
CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (USD MILLION)............................................................................................................................41
• FIGURE 14
STEM CELL BANKING MARKET, BY SERVICES.................................................................................................44
• FIGURE 15
PROCESSING SEGMENT EXPECTED TO CONTINUE LEADING THE STEM CELL BANKING MARKET DURING FORECAST PERIOD..........................................................................45
• FIGURE 16
STEM CELL BANKING MARKET FOR COLLECTION & TRANSPORTATION, BY REGION, 2016 & 2021 (USD MILLION)........................................................................................................46
• FIGURE 17
PROCESSING IS EXPECTED TO BE THE LARGEST SEGMENT OF THE NORTH AMERICAN STEM CELL BANKING MARKET.................................................................................48
• FIGURE 18
STEM CELL BANKING MARKET FOR ANALYSIS, BY REGION, 2016 & 2021 (USD MILLION)............................................................................................................................49
• FIGURE 19
STEM CELL BANKING MARKET FOR STORAGE, BY REGION, 2016 & 2021, (USD MILLION)...........................................................................................................................50
• FIGURE 20
LARGEST NUMBER OF STEM CELLS ARE EXPECTED TO BE UTILIZED TO TREAT LEUKEMIA BY 2021 GLOBALLY........................................................................................54
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
19
LIST OF FIGURES
• FIGURE 21
NORTH AMERICA TO CONTINUE LEADING THE APPLICATION SEGMENT OF THE STEM CELL BANKING MARKET DURING FORECAST PERIOD............................................55
• FIGURE 22
CEREBRAL PALSY IS EXPECTED TO USE THE LARGEST NUMBER OF STEM CELL UNITS IN 2016..........................................................................................................57
• FIGURE 23
NORTH AMERICA IS ESTIMATED TO LEAD THE STEM CELL BANKING MARKET IN THALASSEMIA IN 2016..................................................................................................59
• FIGURE 24
LARGEST NUMBER OF STEM CELLS FROM CORD BLOOD TO BE CONSUMED FOR LEUKEMIA TREATMENT........................................................................................................60
• FIGURE 25
STEM CELL BANKING MARKET IN ANEMIA, BY REGION, 2016 & 2021 (UNITS).............................................62
• FIGURE 26
DIABETES IS EXPECTED TO BE THE FASTEST GROWING SEGMENT OF STEM CELL BANKING MARKET DURING FORECAST PERIOD.....................................................................63
• FIGURE 27
STEM CELL BANKING MARKET IN AUTISM, BY REGION, 2016 & 2021 (UNITS).............................................64
• FIGURE 28
STEM CELL BANKING MARKET IN OTHERS, BY REGION, 2016 & 2021 (UNITS).............................................66
• FIGURE 29
ASIA-PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD....................................................................................................................................68
• FIGURE 30
NORTH AMERICA WILL CONTINUE TO DOMINATE THE STEM CELL BANKING MARKET DURING FORECAST PERIOD..............................................................................................69
• FIGURE 31
NORTH AMERICA STEM CELL BANKING MARKET SNAPSHOT........................................................................71
• FIGURE 32
EUROPE STEM CELL BANKING MARKET SNAPSHOT.......................................................................................75
• FIGURE 33
ASIA-PACIFIC STEM CELL BANKING MARKET SNAPSHOT.............................................................................79
• FIGURE 34
STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2015 (%).......................................................85
• FIGURE 35
CBR SYSTEMS, INC.: BUSINESS OVERVIEW....................................................................................................91
• FIGURE 36
CORDLIFE: BUSINESS OVERVIEW.....................................................................................................................94
• FIGURE 37
CRYO-CELL: BUSINESS OVERVIEW..................................................................................................................97
• FIGURE 38
CRYO-SAVE AG (A GROUP OF ESPERITE): BUSINESS OVERVIEW...................................................................99
• FIGURE 39
VIACORD: BUSINESS OVERVIEW....................................................................................................................104
• FIGURE 40
CHINA CORD BLOOD CORPORATION: BUSINESS OVERVIEW........................................................................110
sales@marketsandmarkets.com
www.marketsandmarkets.com
20
SAMPLE TABLES
TABLE 1
STEM CELL BANKING MARKET FOR PROCESSING, BY REGION, 2014-2021 (USD MILLION) 2014
2015
2016
2021
CAGR (2016–2021)
North America
xx.x
xx.x
xx.x
xx.x
xx.x%
Europe
xx.x
xx.x
xx.x
xx.x
xx.x%
Asia-Pacific
xx.x
xx.x
xx.x
xx.x
xx.x%
Rest of the World
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
REGION
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 2 NORTH AMERICA STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION) 2014
2015
2016
2021
CAGR (2016–2021)
Cord Blood
xx.x
xx.x
xx.x
xx.x
xx.x%
Cord Blood & Cord Tissue
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
TYPE
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
TABLE 3 NORTH AMERICA STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION) 2014
2015
2016
2021
CAGR (2016–2021)
Processing
xx.x
xx.x
xx.x
xx.x
xx.x%
Storage
xx.x
xx.x
xx.x
xx.x
xx.x%
Analysis
xx.x
xx.x
xx.x
xx.x
xx.x%
Collection & Transportation
xx.x
xx.x
xx.x
xx.x
xx.x%
TOTAL
xx.x
xx.x
xx.x
xx.x
xx.x%
SERVICE
Source: Secondary Research, White Papers, Company Annual Reports, Press Releases, and MarketsandMarkets Analysis
sales@marketsandmarkets.com
www.marketsandmarkets.com
21
APPENDIX
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL •
Knowledge Store contains MarketsandMarkets’ unique market insights. As a subscriber you have access to all of the published titles and any new ones added over the course of the subscription period. You can subscribe to specific number of reports or domains of your interest. • KNOWLEDGE STORE ENABLES YOU TO:
•
•
View & download all subscribed reports from a single, online platform
•
•
Contact our analysts to answer any questions related to our reports or request a custom research
•
•
Share comments on specific reports with the other users of your organization
•
•
Suggest titles/topics to our research teams that you would like us to cover in our future reports
•
•
Identify reports published on the high growth markets within your industry
•
Get started now by requesting a demo and learning more about Knowledge store - https://www.mnmks.com/ • FIG: MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
•
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
22
APPENDIX
• FIG: MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE IT INDUSTRY SNAPSHOT •
•
sales@marketsandmarkets.com
www.marketsandmarkets.com
23
RELATED REPORTS
RELATED REPORTS SR. NO.
REPORT TITLE
PUBLISHED DATE
1
CELL CULTURE MARKET By Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) Forecast to 2020
2
BIOPRESERVATION MARKET By Product (Media, Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), Biospecimen (Human Tissue, Stem Cells, Organs), Application (Therapeutic, Regenerative Medicine, Clinical Trials), End User Global Forecast to 2020
sales@marketsandmarkets.com
www.marketsandmarkets.com
February 2016
August 2015
24
ABOUT MNM
MarketsandMarkets is a global market research and consulting company. It is World’s No. 1 in terms of premium market research studies published annually. Serving as a business intelligence partner to Fortune 500 companies across the world, it provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers seventeen industry verticals, including advanced materials, aerospace and defense, agriculture, automotive and transportation, biotechnology, building and construction, chemicals, energy and power, food and beverages, industrial automation, medical devices, mining, minerals and metals, packaging, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright © 2016 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
DISCLAIMER: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets’ research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: 1-888-600-6441 sales@marketsandmarkets.com
sales@marketsandmarkets.com
www.marketsandmarkets.com
25